Position in GH
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$25,355
+$9,745 QoQ
Shares Held
169
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#495
of 594 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cedar Mountain Advisors, LLC holds $196,529 across 13 Diagnostics & Research names. GH ranks #5 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
133 | $37,240 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
67 | $33,591 | |
| 3 | A |
Agilent Technologies, Inc.
|
236 | $31,347 | |
| 4 | DHR |
Danaher Corp /De/
|
157 | $29,905 | |
| 5 | GH |
Guardant Health, Inc.
This page
|
169 | $25,355 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
17 | $9,003 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
14 | $7,370 | |
| 8 | DGX |
Quest Diagnostics Inc
|
33 | $6,994 |
All Filings in GH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,355 | 169 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $15,610 | 169 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||